Meningitis vaccine trial for toddlers aged 12–23 months
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This study tests a vaccine that protects against four common types of meningitis (groups A, C, Y, and W135) in toddlers aged 12–23 months. It helps researchers see if the vaccine is safe and works well for young children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 12 and 23 months old and generally healthy.
- Your child cannot have had a severe allergic reaction to any vaccine or to ingredients in this vaccine (like mannitol, sucrose, or polysaccharides).
- Your child should not have received a meningococcal vaccine recently (within the last 6 months for some types, or any other meningococcal vaccine ever).
- Your child must not have a weakened immune system (from conditions like HIV, long-term steroid use, or organ transplant) or a history of seizures.
- Your child should not have a bleeding disorder or be taking blood thinners that would make injections risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This study tests a booster shot of a meningococcal vaccine (which protects against four types of meningitis) in children who already received the same type of vaccine years ago. The goal is to see if a booster can refresh and strengthen protection against these serious infections.
This study enrolls children and newborns with suspected or confirmed bacterial meningitis. The goal is to understand and improve care for serious infections that affect the lining around the brain.
This study tests an experimental vaccine to protect babies and toddlers from meningitis (a serious infection of the brain and spinal cord). It checks how well the vaccine works and how safe it is in young children.
Hear when a new Epidemic Meningitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.